Del1
General Information
DRACP ID DRACP01029
Peptide Name Del1
Sequence RRIPFWPIPLRWQWPPPWFPPSFPIPRISRKR
Sequence Length 32
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MEC-1 | Chronic lymphocytic leukemia; B-cell chronic lymphocytic leukemia | Leukemia | 80% killing=32μM | MTT assay | 20h | 1 |
Hemolytic Activity Human erythrocytes:25% Hemolysis=32µM
Normal (non-cancerous) Cytotoxicity HaCat: 10% Killing=32µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C204H296N56O36
Absent amino acids ACDEGHMNTVY
Common amino acids P
Mass 466201
Pl 13.2
Basic residues 7
Acidic residues 0
Hydrophobic residues 12
Net charge 7
Boman Index -6455
Hydrophobicity -79.38
Aliphatic Index 60.94
Half Life
Mammalian: 2.8 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 22000
Absorbance 280nm 709.68
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 33036159
Title Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available